{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"data_sharing_plan":["IPD Sharing (as of November 2021): No"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2396235"],"location":["China"],"study_start_month":["1"],"keyword":["Pretreated"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer","description":"This include two parts, part 1 is a dose optimizing study and part 2 is a randomized, controlled study.","dates":{"creation":"2022-01-15"},"accession":"2396235","cross_references":{"ClinicalTrials___gov":["NCT05130021"]}}